CPMV (Mosaic ImmunoEngineering) Operating Cash Flow per Share : $-0.03 (TTM As of Dec. 2024)

View and export this data going back to . Start your Free Trial

What is Mosaic ImmunoEngineering Operating Cash Flow per Share?

Mosaic ImmunoEngineering's operating cash flow per share for the three months ended in Dec. 2024 was $-0.00. Mosaic ImmunoEngineering's operating cash flow per share for the trailing twelve months (TTM) ended in Dec. 2024 was $-0.03.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 31.10% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 51.80% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 35.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Mosaic ImmunoEngineering's Operating Cash Flow per Share or its related term are showing as below:

CPMV' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -158 Med: 20.45 Max: 62.7
Current: 31.1

During the past 13 years, Mosaic ImmunoEngineering's highest 3-Year average Operating Cash Flow per Share Growth Rate was 62.70% per year. The lowest was -158.00% per year. And the median was 20.45% per year.

CPMV's 3-Year OCF Growth Rate is ranked better than
75.08% of 1220 companies
in the Biotechnology industry
Industry Median: 8.9 vs CPMV: 31.10

Mosaic ImmunoEngineering Operating Cash Flow per Share Historical Data

The historical data trend for Mosaic ImmunoEngineering's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mosaic ImmunoEngineering Operating Cash Flow per Share Chart

Mosaic ImmunoEngineering Annual Data

Trend

May15

May16

May17

May18

May19

May20

Dec21

Dec22

Dec23

Dec24

Operating Cash Flow per Share

Get a 7-Day Free Trial

-1.24

-0.10

-0.07

-0.03

Mosaic ImmunoEngineering Quarterly Data
	Feb20	May20	Aug20	Nov20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Operating Cash Flow per Share	Get a 7-Day Free Trial															-0.01	-0.01	-0.02	-	-

Competitive Comparison of Mosaic ImmunoEngineering's Operating Cash Flow per Share

For the Biotechnology subindustry, Mosaic ImmunoEngineering's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Mosaic ImmunoEngineering's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Mosaic ImmunoEngineering's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Mosaic ImmunoEngineering's Price-to-Operating-Cash-Flow falls into.

Save Embed

;

Save Embed

;

Mosaic ImmunoEngineering Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Mosaic ImmunoEngineering's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2024 is calculated as

Operating Cash Flow per Share (A: Dec. 2024 )	=	Cash Flow from Operations (A: Dec. 2024 )	/	Shares Outstanding (Diluted Average) (A: Dec. 2024 )
	=	-0.241	/	7.236
	=	-0.03

Mosaic ImmunoEngineering's Operating Cash Flow per Share for the quarter that ended in Dec. 2024 is calculated as

Operating Cash Flow per Share (Q: Dec. 2024 )	=	Cash Flow from Operations (Q: Dec. 2024 )	/	Shares Outstanding (Diluted Average) (Q: Dec. 2024 )
	=	-0.021	/	7.236
	=	-0.00

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.03

Mosaic ImmunoEngineering Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Mosaic ImmunoEngineering's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Mosaic ImmunoEngineering Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Mosaic ImmunoEngineering Inc (OTCPK:CPMV) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

9114 Adams Avenue, Suite 202, Huntington Beach, CA, USA, 92646

Website

https://www.mosaicie.com

Mosaic ImmunoEngineering Inc is a development-stage biotechnology company focused on bridging immunology and engineering to develop novel immunotherapies to treat and prevent cancer and infectious diseases. It has a single operating segment for the purposes of assessing performance and making operating decisions.

Executives

Robert Baffi	director	C/O BIOMARIN PHARMACEUTICAL INC., 105 DIGITAL DRIVE, NOVATO CA 94949
Case Western Reserve University	10 percent owner	10900 EUCLID AVENUE, CLEVELAND OH 44106
Steven W King	director, officer: President and CEO
Paul J Lytle	director, officer: EVP, Chief Financial Officer
Robert L Garnick	director	C/O PATRIOT SCIENTIFIC, 2038 CORTE DEL NOGAL, SUITE 141, CARLSBAD CA 92011
Nicole Franziska Steinmetz	director, officer: Chief Scientific Officer	871 WILBUR AVENUE, SAN DIEGO CA 92019
Dharmesh Mistry	director	315 PEMBROKE COURT, SAN RAMON CA 94582
Carlton M Johnson	director
Donald E Schrock	director	C/O INTEGRATED DEVICE TECHNOLOGY, INC., 6024 SILVER CREEK VALLEY ROAD, SAN JOSE CA 95138
Paul R Bibeau	officer: VP, Business Development	MICROSEMI CORP, 2381 MORSE AVE, IRVINE CA 92614
Frederick C Goerner	officer: Chief Executive Officer	MICROSEMI CORPORATION, ONE ENTERPRISE, ALISO VIEJO CA 92656
Clifford L Flowers	officer: Chief Financial Officer	C/O BAKBONE SOFTWARE, INC., 9540 TOWNE CENTRE DRIVE, SUITE 100, SAN DIEGO CA 92121
Harry L Tredennick	director	6183 PASEO DEL NORTE #180, CARLSBAD CA 92011
Thomas J Sweeney	officer: CFO
Helmut Jr Falk	director